Prevalence of resistance and HIV-1 protease mutation patterns after failures with fosamprenavir-containing regimens

Eitemau Tebyg

• Darunavir resistance spectrum in darunavir-na#239;ve patients harboring virological failure to antiretroviral therapy
  gan: Marcelin, AG, et al.
  Cyhoeddwyd: (2010)
• Less frequent follow-up in routine care than in trials does not impact resistance selection in patients failing DRV/r or ATV/r first line treatment
  gan: Marcelin, Anne-Genevieve, et al.
  Cyhoeddwyd: (2014)
• Genotypic Resistance Analysis of the Virological Response to Fosamprenavir-Ritonavir in Protease Inhibitor-Experienced Patients in CONTEXT and TRIAD Clinical Trials
  gan: Marcelin, Anne-Geneviève, et al.
  Cyhoeddwyd: (2008)
• Treatment-Emergent Mutations and Resistance in HIV-Infected Children Treated with Fosamprenavir-Containing Antiretroviral Regimens
  gan: Ross, Lisa L, et al.
  Cyhoeddwyd: (2015)
• Factors Associated with the Selection of Mutations Conferring Resistance to Protease Inhibitors (PIs) in PI-Experienced Patients Displaying Treatment Failure on Darunavir
  gan: Lambert-Niclot, Sidonie, et al.
  Cyhoeddwyd: (2008)